Open Access

Figure 3.


Download original image

Effects of Spadin on the TREK-1 channel activity. A-B) Whole-cell currents measured in COS-7 transfected cells in presence of potassium blockers (K+ blockers, 10 mM tetraethyl ammonium (TEA), 3 mM 4-aminopyridine (4-AP), 50 nM charybdotoxin, 10 μM glibenclamide, 100 nM apamin). Cells are clamped at -80 mV and voltage changes are applied by ramp from -100 to 50 mV, 1 s in duration Currents are recorded after TREK-1 activation by 10 μM arachidonic acid (aa) and aa + Spadin (100 nM) (A) or aa + propeptide (PE, 500 nM) (B). Native currents are recorded in the absence (Control) and in the presence of spadin or PE. C) Dose-dependent spadin inhibition of TREK-1 currents, IC50 value at 0 mV is of 70.7 nM. Currents are measured in the presence of 10 μM aa. D, Native currents recorded in the presence of K+ blockers after stimulation by 10 μM of aa on CA3 pyramidal neurons from hippocampus slices in wild-type mice (D) or in kcnk2 deficient mice (TREK-1 KO) (Inset) in the presence or the absence of spadin (1 μM). Currents are elicited by a ramp from –100 mV to 50 mV.

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.